Search results for: "johnson johnson"

(728 records)
* We recommend refining your query to help us better locate the information you're seeking.

Appointment of Amgen Executive Director as Chief Executive

Appointment of Amgen Executive Director as Chief Executive

e-Therapeutics plc, the drug discovery company, announces that it has appointed Dr. Raymond Barlow as Chief Executive Officer.
Ingredients
Johnson Matthey launches new online catalyst store

Johnson Matthey launches new online catalyst store

Johnson Matthey, a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, is pleased to announce the launch of its new...

Oxular appoints David Fellows as Chairman of the Board

David has more than 30 years of experience in various leadership roles within the ophthalmic pharmaceutical industry

Pharmalink strengthens board with appointment of Maria Carell as Chair

Pharmalink AB, a specialty pharma company, announces the election of Maria Carell as Chair of the company’s board of directors.
Ingredients
Chief Executive of Johnson Matthey meets local community at Annan to discuss successful investment into Scotland

Chief Executive of Johnson Matthey meets local community at Annan to discuss successful investment into Scotland

Johnson Matthey, a leader in science and technologies that make the world cleaner and healthier, has announced that Robert MacLeod, Chief Executive of Johnson Matthey, and John...
Finance
Concept Life Sciences appoints Tony Johnson as Group Business Development Executive

Concept Life Sciences appoints Tony Johnson as Group Business Development Executive

Knowledge based, science led business, Concept Life Sciences, has further strengthened its team with the appointment of Tony Johnson as Group Business Development Executive.

Action Plan for UK to capture the next generation of medicines manufacturing jobs

Taskforce calls on Government to make the UK the go to destination for international investment in ground-breaking medicinal therapies.
You need to be a subscriber to read this article.
Click here to find out more.
Containment
Potent oral solid dosage APIs: containment fundamentals

Potent oral solid dosage APIs: containment fundamentals

The last 20 years have seen a significant increase in the need for contained handling and processing in the pharmaceutical industry, driven by the development of more potent...
Hi Tech Manufacturing
British AI firm announces license agreement with Janssen for clinical stage drug candidates

British AI firm announces license agreement with Janssen for clinical stage drug candidates

BenevolentAI, a leading British artificial intelligence (AI) company, has announced significant progress in one of its key ambitions: to improve and innovate the drug...
Regulatory
MHRA designates VTS-270 as a promising innovative medicine

MHRA designates VTS-270 as a promising innovative medicine

Designation is first step to inclusion in Early Access to Medicines Scheme (EAMS), providing patients with faster access to innovative medicines
Recruitment
Almac Group appoints Dr Victor Diaz Perez as Head of Physical Sciences

Almac Group appoints Dr Victor Diaz Perez as Head of Physical Sciences

Dr Diaz will further complement the existing physical sciences team, bringing considerable experience in research and development within solid state chemistry

Abzena makes two senior executive appointments to drive growth of international business

Abzena provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products
Design & Build
Quotient clinical expands data sciences capability

Quotient clinical expands data sciences capability

Department moves into enhanced facility and increases headcount in response to continued demand for services
Ingredients
Johnson Matthey's Annan, UK site receives MHRA certification for GMP manufacturing

Johnson Matthey's Annan, UK site receives MHRA certification for GMP manufacturing

The company has made significant investments to refurbish the site, which is now fully equipped for GMP manufacturing
Media
Large molecules enjoy greater success rates than small

Large molecules enjoy greater success rates than small

From early phase to approval, small molecules have a 5% chance of success compared with 13% for large

PureTech's Gelesis appoints chief operating officer and vice president of medical affairs

Former Boehringer Ingelheim vice president will lead commercialisation and operations efforts

Trending Articles

  1. Takara Bio extends biomanufacturing capabilities with custom enzyme manufacturing lab Its Gothenburg facility now has a manufacturing lab that can produce customised molecular biology products such as PCR and qPCR enzymes
  2. Axplora earns EcoVadis Platinum, Gold and Silver ratings across four European CDMO manufacturing sites The sustainability ratings recognise Axplora's progress in responsible pharmaceutical manufacturing, with its Leverkusen facility ranking among the top 1% of organisations assessed by EcoVadis
  3. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    ESG: transforming the pharmaceutical supply chain As pharmaceutical businesses place greater scrutiny on the environmental performance of their supply chains, manufacturers are under growing pressure to show that sustainability is embedded in the way they operate
  5. Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones Piramal Pharma Limited (PPL) (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platform, investing in differentiated capabilities, advancing sustainability, and delivering quality across operations

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Personal Protection New immersive innovation hub near Coimbra combines safety training, product testing and collaborative R&D to support the future of workplace protection
Ansell opens AXIS Portugal to accelerate PPE innovation in Europe

Ansell opens AXIS Portugal to accelerate PPE innovation in Europe

Read more
Hi Tech Manufacturing Linking the digital twin of the mould with production data. Virtual mould and process optimisation prior to physical construction Mould Lifecycle Management as the foundation...
Gerresheimer significantly accelerates mould development in medical technology with “Digital Mold”

Gerresheimer significantly accelerates mould development in medical technology with “Digital Mold”

Read more
Manufacturing Brings decentralised, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

Read more
Manufacturing The pharma giant is consolidating parts of its manufacturing network as it advances a $55bn US investment programme aimed at expanding domestic production of advanced medicines
Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Read more
Manufacturing ten23 health today highlights its research collaboration with dsm-firmenich, focused on expanding excipient options for parenteral biologic drug products
ten23 health expands excipient options for biologic drug development with an external collaboration

ten23 health expands excipient options for biologic drug development with an external collaboration

Read more
Design & Build The clinical-stage biotech has relocated to ARC Oxford, strengthening its R&D capabilities as it progresses clinical trials of its oncolytic immunotherapy candidate THEO-260...
Theolytics expands Oxford biotech operations with new facility to advance THEO-260 cancer immunotherapy

Theolytics expands Oxford biotech operations with new facility to advance THEO-260 cancer immunotherapy

Read more
Research & Development In discussion with Dr Kevin Robinson (KSR), Neurvati’s Dr Bruce Leuchter (BL) explores how biology-led development, better diagnosis and rare disease infrastructure could...
Precision medicine and the fight to revive neuroscience R&D

Precision medicine and the fight to revive neuroscience R&D

Read more
Manufacturing A leading biopharmaceutical manufacturer in England is realising substantial energy savings after upgrading its ageing compressed air system with Atlas Copco’s oil-free VSD+...
Pharmaceutical company cuts energy use and achieves ISO compliance with compressor and dryer upgrade

Pharmaceutical company cuts energy use and achieves ISO compliance with compressor and dryer upgrade

Read more